BioCentury
ARTICLE | Clinical News

FDA panel to discuss Pfizer's Xeljanz for UC

January 26, 2018 8:17 AM UTC

FDA's Gastrointestinal Drugs Advisory Committee will meet on March 8 to discuss an sNDA from Pfizer Inc. (NYSE:PFE) for Xeljanz tofacitinib tablets to treat adults with moderate to severe active ulcerative colitis...

BCIQ Company Profiles

Pfizer Inc.